Le Lézard
Classified in: Science and technology
Subjects: PDT, PER, ACC

INFOLOB Solutions, Inc. Announces Company Reorganization


IRVING, Texas, Jan. 2, 2023 /PRNewswire/ -- Taking a substantial step towards its target of delivering flawless Oracle infra and apps services and solutions to global enterprises ? INFOLOB Solutions, Inc. announces the completion of company reorganization, effective 01/01/2023.

The restructuring of the company now results in two different legal entities: INFOLOB Global, Inc. and INFOLOB Solutions, Inc. The new company, INFOLOB Global, Inc. is created by the way of an intercompany reorganization process and will assume the existing "INFOLOB" logo as well as the domain www.infolob.com. The entity will focus on Oracle Cloud infra, cloud apps, data, and digital practice areas across NA, EMEA, and LATAM.

On the other hand, the old corporation, INFOLOB Solutions, Inc., will continue its focus on IT consulting and staffing services under the guidance of Nivas Nadimpalli as the Chief Executive Officer.

Speaking about the reorganization, INFOLOB's founder and CEO, Mr. Vijay Cherukuri says "We made aggressive expansions across EMEA and APAC in 2022 with fantastic results and a few new insights. One of those insights was the need of this company reorganization that will support our ability to meet a global clientele at their doorsteps with our unparalleled Oracle technology enablement expertise. Our onshore, offshore, and nearshore models make up an irresistible value proposition for our customers, and INFOLOB Global, Inc. as a new legal business entity will help us accelerate quicker. Additionally, this change will have no material impact on our customers, employees, and will represent an enhanced platform for Infolob continued growth more efficiently across the globe"

"I am proud of a remarkable leadership team that INFOLOB has assembled in the past decade with some of the technology stalwarts associating with us, especially Tim Fox, Josh Turnbull, Satyendra Kumar, Srinivasakumar Doppalapudi, Vidya Sagar, Yzelle Conrad De Wet, Senthil Prabu, Rajkumar Sabbathi, and Mahendra Padmaraju." Says Mr. Cherukuri.

Vijay adds further, "While www.virtuegroup.com is run by Raghu Bhupathiraju and www.infolobsolutions.com by Nivas ? I will be overseeing internal controls, business strategy, board governance, compliance, and making sound financial decisions for both organizations with 90% of my time being spent on www.infolob.com, with Tim and Josh helping me in North America and Satyendra, DSK, and Senthil helping in EMEA and APAC regions to effectively grow the organization across the globe."

For all queries, please write to [email protected]

Logo - https://mma.prnewswire.com/media/1387377/Infolob_Logo.jpg

SOURCE Infolob Solutions, Inc.


These press releases may also interest you

at 21:09
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

at 20:55
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

at 20:45
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

at 20:07
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...

at 20:05
Enterprises in Asia Pacific are moving toward software-defined networking (SDN) to make communication more secure and resilient and speed up business decision-making, according to a new research report published today by Information Services Group...

at 20:00
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced that Pascal...



News published on and distributed by: